Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixisenatide vs Liraglutide Pharmacodynamics in T2DM
NCT01175473Phase 2Completed
- Sponsor
- Sanofi
- Start
- Aug 2010
- Primary completion
- Nov 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of lixisenatide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Sanofi. Primary endpoint: Area Under the Plasma Glucose Concentration Curve at Day 28. Started Aug 2010; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01175473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01175473.